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Résumé en
anglais
Charcot-Marie-Tooth (CMT) disease represents a large group of clinically and
genetically heterogeneous disorders leading to inherited peripheral neuropathies
affecting motor and sensory neurons. Mutations in the ganglioside-induced
differentiation-associated-protein 1 gene (GDAP1), which encodes a protein
anchored to the mitochondrial outer membrane, are usually associated with the
recessive forms of CMT disease and only rarely with the autosomal dominant forms.
The function of GDAP1 is not fully understood but it plays a role in mitochondrial
dynamics by promoting fission events. We present an overview of GDAP1 and the
corresponding protein together with the complete spectrum of the 41 gene
mutations described so far. We examine the relationship between the genotype and
the phenotype in the various forms of CMT disease related to GDAP1 mutations, and
discuss the pathophysiological hypotheses that link peripheral neuropathies to
mitochondrial dysfunction and GDAP1 mutations. The meta-analysis of the literature
reveals the great heterogeneity of phenotypic presentations and shows that the
recessive forms of CMT disease, i.e. CMT4A and AR-CMT2, are far more severe than
the dominant form, i.e. CMT2K. Among patients with recessive forms of the disease,
those carrying truncating mutations are more seriously affected, often becoming
wheelchair-bound before the end of the third decade. At the neuronal level, GDAP1
mutations may lead to perturbed axonal transport and impaired energy production
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